PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 14, 2026Frontiers in Cardiovascular Medicine1 citationsOpen Access

Myocardial radiomics of non-ischemic cardiomyopathy using cardiovascular magnetic resonance: current perspectives and future directions

SZSamir ZamanPSPrabhu SasankanAAAmine Amyar

Key Result

Machine learning models using radiomic features from non-contrast cardiac MRI sequences demonstrated diagnostic accuracies with AUCs ranging from 0.74 to 0.96 for detecting myocardial fibrosis and differentiating subtypes of non-ischemic cardiomyopathy, potentially reducing the need for gadolinium contrast.

Key Points

  • The aim is to explore the application of radiomic analysis using cardiovascular magnetic resonance in non-ischemic cardiomyopathy.
  • Review of cardiovascular magnetic resonance as a diagnostic tool.
  • Discussion of radiomic analysis and its quantitative capabilities.
  • Overview of machine learning applications in myocardial evaluation.
  • Radiomic analysis can provide detailed insights beyond visual assessments.
  • Machine learning enhances diagnostic accuracy for non-ischemic cardiomyopathy.
  • Integrating these tools into clinical practice holds significant potential for personalized care.

PICO

P
Population
Patients with non-ischemic cardiomyopathy including hypertrophic cardiomyopathy, dilated cardiomyopathy, cardiac amyloidosis, cardiac sarcoidosis, and myocarditis evaluated by cardiovascular magnetic resonance
I
Intervention / Comparator
Radiomic analysis combined with machine learning models applied to cardiovascular magnetic resonance imaging vs Standard CMR metrics or no radiomic analysis
O
Primary Outcome
Diagnostic accuracy for detection or differentiation of myocardial fibrosis, histologic phenotypes, or specific cardiomyopathies such as HCM, DCM, cardiac amyloidosis, sarcoidosis, or myocarditis using radiomics with ML

Limitations

  • This is a review article summarizing retrospective, mainly single-center studies with relatively small sample sizes.
  • Variability in imaging protocols and scanners limit reproducibility and generalizability of radiomic models.
  • Interpretability of radiomic features remains limited, posing challenges for clinical integration.
  • Most studies lack prospective or randomized controlled trial validation.
  • Ethical, regulatory, and privacy challenges exist for implementing AI-based radiomics in clinical practice.

Abstract

Heart failure remains a major source of global morbidity and mortality, frequently driven by the structural and functional myocardial changes associated with ischemic and non-ischemic cardiomyopathies. While cardiovascular magnetic resonance (CMR) is the gold standard for non-invasive ventricular assessment, standard clinical measures rely on visual human interpretation. By contrast, radiomic analysis, a high-throughput computational approach that can extract quantitative features beyond the limits of visual perception, has gained interest in its application to CMR for detailed evaluation of myocardial properties. Over the last decade, novel studies integrating radiomics with machine learning (ML) algorithms may enable more accurate diagnosis and personalized characterization of non-ischemic cardiomyopathy beyond traditional CMR sequences, and without the use of gadolinium-based contrast agents. This review provides an overview of CMR radiomic analysis, summarizes recent applications of ML workflows in non-ischemic cardiomyopathy, and discusses the challenges and opportunities in integrating these computational tools into clinical practice.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zaman et al. (2026) conducted a review in Patients with non-ischemic cardiomyopathy including hypertrophic cardiomyopathy, dilated cardiomyopathy, cardiac amyloidosis, cardiac sarcoidosis, and myocarditis evaluated by cardiovascular magnetic resonance. Radiomic analysis combined with machine learning models applied to cardiovascular magnetic resonance imaging vs. Standard CMR metrics or no radiomic analysis was evaluated on Diagnostic accuracy for detection or differentiation of myocardial fibrosis, histologic phenotypes, or specific cardiomyopathies such as HCM, DCM, cardiac amyloidosis, sarcoidosis, or myocarditis using radiomics with ML. Machine learning models using radiomic features from non-contrast cardiac MRI sequences demonstrated diagnostic accuracies with AUCs ranging from 0.74 to 0.96 for detecting myocardial fibrosis and differentiating subtypes of non-ischemic cardiomyopathy, potentially reducing the need for gadolinium contrast.

synapsesocial.com/papers/699010382ccff479cfe56d41https://doi.org/10.3389/fcvm.2026.1637962
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cardiovascular magnetic resonance imaging: emerging techniques and applications2021 · 35 citations
  2. 2Automated quantification of myocardial tissue characteristics from native T1 mapping using neural networks with uncertainty-based quality-control2020 · 48 citations
  3. 3Cardiovascular Magnetic Resonance Radiomics to Identify Components of the Extracellular Matrix in Dilated Cardiomyopathy2024 · 27 citations
  4. 4Machine learning phenotyping of scarred myocardium from cine in hypertrophic cardiomyopathy2021 · 43 citations
  5. 5Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms2016 · 766 citations